Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company ...
Leadership
Randal J. Kirk J.D.
Executive Chairman
Helen Sabzevari MPH, Ph.D.
President, CEO & Director
Harry Thomasian Jr.
Chief Financial Officer
Rutul R. Shah
Chief Operating Officer
Donald P. Lehr J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
Phil Tennant
Chief Commercial Officer
Steven M. Harasym
VP & Head of Investor Relations
Douglas E. Brough Ph.D.
Senior VP & Head of Research
Bryan T. Butman Ph.D.
Senior VP & Head of CMC
Amy R. Lankford Ph.D.
Senior VP & Head of Clinical Operations and Regulatory Affairs
